Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Insulin breast cancer connection: confirmatory data set the stage for better care.

DeCensi A, Gennari A.

J Clin Oncol. 2011 Jan 1;29(1):7-10. doi: 10.1200/JCO.2010.32.3022. Epub 2010 Nov 29. No abstract available.

2.

[Natural history of insulin resistance and hyperinsulinism in non-insulin-dependent diabetic patients].

Vague P, Raccah D.

Journ Annu Diabetol Hotel Dieu. 1990:201-9. Review. French. No abstract available.

PMID:
2195206
3.

[Theoretical aspects of the relationship between diabetic macroangiopathy and hyperinsulinism].

Leutenegger M.

Presse Med. 1992 Sep 9;21(28):1324-9. Review. French.

PMID:
1438101
4.

Diabetes, insulin, and risk of cancer.

Schiel R, Beltschikow W, Steiner T, Stein G.

Methods Find Exp Clin Pharmacol. 2006 Apr;28(3):169-75. Review.

PMID:
16810343
5.

Insulinemia and the risk of breast cancer and its relapse.

Formica V, Tesauro M, Cardillo C, Roselli M.

Diabetes Obes Metab. 2012 Dec;14(12):1073-80. doi: 10.1111/j.1463-1326.2012.01614.x. Epub 2012 May 17. Review.

PMID:
22537210
6.

Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.

Reaven GM.

Diabetes Metab Rev. 1993 Nov;9 Suppl 1:5S-12S. Review. No abstract available.

PMID:
8299489
8.

[Hyperinsulinism syndromes caused by insulin resistance].

Robert JJ.

Ann Pediatr (Paris). 1990 Mar;37(3):143-9. Review. French.

PMID:
2190520
9.

Pathogenesis of type 2 diabetes mellitus.

DeFronzo RA.

Med Clin North Am. 2004 Jul;88(4):787-835, ix. Review.

PMID:
15308380
10.

[Insulin resistance and cardiovascular complications].

Janka HU.

Wien Klin Wochenschr. 1994;106(24):758-62. Review. German.

PMID:
7846894
11.

Fatty acids, hyperinsulinemia, and insulin resistance: which comes first?

Björntorp P.

Curr Opin Lipidol. 1994 Jun;5(3):166-74. Review.

PMID:
7952910
12.

[Diabetes, insulin, insulin analogues, and cancer].

Müssig K, Staiger H, Kantartzis K, Fritsche A, Kanz L, Häring HU.

Dtsch Med Wochenschr. 2010 May;135(18):924-9. doi: 10.1055/s-0030-1253681. Epub 2010 Apr 27. Review. German.

PMID:
20425680
13.

Hyperinsulinism and dyslipidemias as coronary heart disease risk factors in NIDDM.

Taskinen MR.

Adv Exp Med Biol. 1993;334:295-301. Review.

PMID:
8249693
14.

Epidemiology of insulin resistance and its relation to coronary artery disease.

Haffner SM.

Am J Cardiol. 1999 Jul 8;84(1A):11J-14J. Review.

PMID:
10418852
15.

[Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].

Bretzel RG.

Wien Klin Wochenschr. 1994;106(24):774-92. Review. German.

PMID:
7846897
16.

Insulin signal transduction in normal cells and its role in carcinogenesis.

Müssig K, Häring HU.

Exp Clin Endocrinol Diabetes. 2010 Jun;118(6):356-9. doi: 10.1055/s-0029-1243603. Epub 2010 Feb 5. Review.

PMID:
20140848
17.

Clinical efficacy of metformin against insulin resistance parameters: sinking the iceberg.

Zimmet P, Collier G.

Drugs. 1999;58 Suppl 1:21-8; discussion 75-82. Review.

PMID:
10576521
18.

Assessment of patients with acanthosis nigricans skin lesion for hyperinsulinemia, insulin resistance and diabetes risk.

Gilkison C, Stuart CA.

Nurse Pract. 1992 Feb;17(2):26, 28, 37 passim. Review.

PMID:
1542462
19.

Clinical significance of insulin resistance.

Bell PM.

Diabet Med. 1996 Jun;13(6):504-9. Review.

PMID:
8799651
20.

The insulin resistance syndrome: the controversy is dead, long live the controversy!

Stern MP.

Diabetologia. 1994 Sep;37(9):956-8. Review. No abstract available.

PMID:
7806029
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk